Categories: World

Health tech firm Revvity misses Q3 revenue estimates, announces $1 bln buyback program

Published by TSG Syndication

Overview * Revvity Q3 revenue of $699 mln missed analyst expectations * Adjusted EPS from continuing operations was $1.18, down from $1.28 last year * Company authorizes new $1 bln share repurchase program Outlook * Revvity updates 2025 revenue guidance to $2.83-$2.88 bln due to currency changes * Company reaffirms 2025 organic growth guidance of 2% to 4% * Revvity raises 2025 adjusted EPS guidance to $4.90-$5.00 Result Drivers * STRATEGIC PARTNERSHIPS - CEO Prahlad Singh attributes Q3 performance to key innovations and strategic partnerships * SHARE REPURCHASE - Co authorizes new $1 bln share repurchase program, replacing prior program Key Details Metric Beat/Mis Actual Consensu s s Estimate Q3 Miss $698.94 $700.45 Revenue mln mln (16 Analysts ) Q3 EPS $0.40 Q3 $1.18 Adjusted EPS continui ng operatio ns Press Release: For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact . (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.) (The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
TSG Syndication
Published by TSG Syndication